Clinical Trial: SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction

U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07597902) titled 'SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction' on May 14.

Brief Summary: The purpose of this research study is to test if the combination of three drugs, valacyclovir, celecoxib, and Paxlovid will decrease the symptoms of Long COVID in adults compared to a placebo (this does not contain the medications).

Study Start Date: June 01

Study Type: INTERVENTIONAL

Condition: Post-acute Sequelae of COVID-19 Long COVID

Intervention: DRUG: Valacyclovir

one to two 750mg capsules taken orally in the morning and evening

DRUG: Celecoxib

200mg capsules taken orally in the morning and evening

DRUG: Paxlovid

one (1...